eJHaem Publication and MATRON Audit Spotlight Gaps in Pulmonary Embolism Care for Pregnant Patients
Giulia Simini, Haematology Resident at at University College London (UCL), has shared a post on Linkedin:
“New publication out in eJHaem:
‘Physician Survey on the Management of Pulmonary Embolism in Pregnancy: Need for Guidance and Training’
Our survey reveals significant challenges in managing pulmonary embolism (PE) during pregnancy —an area where uncertainty remains high. Key takeaways include:
- A pressing need for high-quality, real-world data on the management of intermediate- and high-risk PE in pregnancy
- Significant gaps in clinician training and limited access to advanced therapies
- Wide variability in clinical practice and perceptions of the usefulness of advanced interventions
- Uneven distribution and underutilization of Pulmonary Embolism Response Teams (PERTs)
In direct response to these findings, we launched MATRON – a national, multicenter audit focused on the management of high-risk and intermediate-high-risk PE in pregnancy.
By capturing real-world data across the UK, MATRON aims to fill critical evidence gaps and lay the groundwork for future clinical guidance. Results from first round of data collection will be shared soon.
A huge thank you to our collaborators and all the clinicians who contributed to this work.”
You can check the MATRON webpage here
Title: Physician Survey on the Management of Pulmonary Embolism in Pregnancy: Need for Guidance and Training
Authors: Giulia Simini, Richard Buka, Daniel Kajita, Omar Mukhlif, HaemSTAR collaborators, Gill Swallow, Pip Nicolson, Sajida Kazi
Read the full article here.
Stay informed with Hemostasis Today.
-
Sep 18, 2025, 06:50Fetal Hereditary TTP Featured in NEJM – Senior Author Nishant Rajendra Tiwari
-
Sep 17, 2025, 10:54Mitapivat Boosts ATP in Red Cells: Dr. William Aird on New Hope for Hemolytic Disorder
-
Sep 17, 2025, 08:16Superficial Vein Thrombosis Management: John Fanikos Shares Latest Review
-
Sep 17, 2025, 07:00Maha Othman - ''BIC 2025 is Without a Doubt a Remarkable Scientific Event — and I’m Excited for What Lies Ahead!''
-
Sep 16, 2025, 11:17Glenn Pierce: WHO Issues a Biannual Essential Medicines List
-
Sep 18, 2025, 07:00Rishabh Singh on NEJM Letter: FVIII Aurora Mutation Shows Increased Activity and Reduced APC Response
-
Sep 18, 2025, 02:25Flora Peyvandi Highlights 'Inflammatory Memory of Stem Cells' – New Insights for Hematologic Diseases
-
Sep 17, 2025, 16:32Endovascular Today: Dr. Eric Secemsky Analyzes Impact of Paclitaxel Pause on Peripheral Artery Disease Care
-
Sep 17, 2025, 16:28Haemnet Showcases Research on Severe Haemophilia A Patients Adapting to Emicizumab Therapy
-
Sep 17, 2025, 16:19Todd Villines: Coronary Artery Disease - A BIG Movement to Change
-
Sep 16, 2025, 14:59A New Era in Antiplatelet Therapy for CABG?
-
Sep 16, 2025, 07:44Artificial Blood Breakthrough in Japan: Long Shelf Life, No Type Matching, and a Purple Future
-
Sep 16, 2025, 02:44Wolfgang Miesbach Highlights First Inhibitor Case After Hemophilia A Gene Therapy (Giroctocogene Fitelparvovec)
-
Sep 12, 2025, 15:21Christian Schäfer: INR Self-Management Has Officially Been Given Class IA Status in the ESC Guidelines
-
Sep 9, 2025, 20:15Linking a Single Dominant Antibody to HIT: A Novel Study Led by Ishac Nazy, Donald Arnold, and John G. Kelton
-
Sep 18, 2025, 06:34'A New Era in Mechanical Thrombectomy?' – Sripal Bangalore Highlights SYMPHONY-PE IDE Study
-
Sep 17, 2025, 10:49Living with Glanzmann Thrombasthenia․ Eliza VanZweden’s Story of Resilience and Advocacy
-
Sep 17, 2025, 10:22Abdul Mannan: Turning Medical Podcasts into Active Learning with Structured Tools
-
Sep 17, 2025, 09:43Global Blood Supply Under Threat: David McIntosh Calls for Action to Support Transfusion Services
-
Sep 17, 2025, 09:08Coronary Arteries, Pericardial Cavity, and the Hidden Danger of Cardiac Tamponade During PCI-By Ahmed Ata